{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:39:40Z","timestamp":1794645580676,"version":"4.9.1"},"reference-count":276,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/gme.0b013e3181c617e6","type":"journal-article","created":{"date-parts":[[2010,1,5]],"date-time":"2010-01-05T03:17:35Z","timestamp":1262661455000},"page":"25-54","source":"Crossref","is-referenced-by-count":358,"title":["Management of osteoporosis in postmenopausal women"],"prefix":"10.1097","volume":"17","member":"276","reference":[{"key":"R1-11-20210227","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/01.gme.0000222475.93345.b3","article-title":"The management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society.","volume":"13","year":"2006","journal-title":"Menopause"},{"key":"R2-11-20210227","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1001\/jama.1995.03530220066035","article-title":"Users' guides to the medical literature. IX. A method for grading health care recommendations. Evidence-Based Medicine Working Group.","volume":"274","author":"Guyatt","year":"1995","journal-title":"JAMA"},{"key":"R3-11-20210227","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1136\/bmj.317.7156.427","article-title":"Guidelines for clinical guidelines editorial.","volume":"317","author":"Jackson","year":"1998","journal-title":"BMJ"},{"key":"R5-11-20210227","first-page":"67","article-title":"The North American Menopause Society develops consensus opinions editorial.","volume":"5","author":"Boggs","year":"1998","journal-title":"Menopause"},{"key":"R6-11-20210227","first-page":"785","article-title":"Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy.","volume":"85","year":"2001","journal-title":"JAMA"},{"key":"R7-11-20210227","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1007\/BF01622200","article-title":"Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group.","volume":"4","author":"Kanis","year":"1994","journal-title":"Osteoporos Int"},{"issue":"suppl 1","key":"R8-11-20210227","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1007\/BF01623429","article-title":"Peak bone mass.","volume":"4","author":"Bonjour","year":"1994","journal-title":"Osteoporos Int"},{"key":"R9-11-20210227","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults.","volume":"8","author":"Looker","year":"1998","journal-title":"Osteoporos Int"},{"issue":"suppl 3","key":"R10-11-20210227","doi-asserted-by":"crossref","first-page":"S203","DOI":"10.1016\/8756-3282(95)00503-X","article-title":"Forearm fracture.","volume":"18","author":"Eastell","year":"1996","journal-title":"Bone"},{"key":"R11-11-20210227","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1359\/jbmr.1997.12.11.1761","article-title":"Prevalence of low femoral bone density in older U.S. adults from NHANES III.","volume":"12","author":"Looker","year":"1997","journal-title":"J Bone Miner Res"},{"key":"R12-11-20210227","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1359\/jbmr.1997.12.1.16","article-title":"Fractures attributable to osteoporosis: report from the National Osteoporosis Foundation.","volume":"12","author":"Melton","year":"1997","journal-title":"J Bone Miner Res"},{"key":"R13-11-20210227","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archinte.164.10.1108","article-title":"Bone mineral density thresholds for pharmacological intervention to prevent fractures.","volume":"164","author":"Siris","year":"2004","journal-title":"Arch Intern Med"},{"key":"R14-11-20210227","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1359\/jbmr.2003.18.11.1947","article-title":"BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures.","volume":"18","author":"Stone","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R15-11-20210227","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1210\/jc.2004-1568","article-title":"Hip fracture in women without osteoporosis.","volume":"90","author":"Wainwright","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 2","key":"R16-11-20210227","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1007\/s00198-004-1702-6","article-title":"Epidemiology of osteoporotic fractures.","volume":"16","author":"Johnell","year":"2005","journal-title":"Osteoporos Int"},{"key":"R17-11-20210227","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jbmr.5650070902","article-title":"How many women have osteoporosis?","volume":"7","author":"Melton","year":"1992","journal-title":"J Bone Miner Res"},{"key":"R18-11-20210227","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1359\/JBMR.041007","article-title":"Osteoporosis and fracture risk in women of different ethnic groups.","volume":"20","author":"Barrett-Connor","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R19-11-20210227","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1001\/jama.293.17.2102","article-title":"Bone mineral density and the risk of incident nonspinal fractures in black and white women.","volume":"293","author":"Cauley","year":"2005","journal-title":"JAMA"},{"key":"R20-11-20210227","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2009.1231","article-title":"Trends in hip fracture rates in Canada.","volume":"302","author":"Leslie","year":"2009","journal-title":"JAMA"},{"key":"R21-11-20210227","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1001\/jama.285.3.320","article-title":"Risk of new vertebral fracture in the year following a fracture.","volume":"285","author":"Lindsay","year":"2001","journal-title":"JAMA"},{"key":"R22-11-20210227","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1359\/jbmr.2000.15.4.721","article-title":"Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis.","volume":"15","author":"Klotzbuecher","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R23-11-20210227","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1002\/1529-0131(200111)44:11<2611::AID-ART441>3.0.CO;2-N","article-title":"The relationship of health-related quality of life to prevalent and incident vertebral fractures in postmenopausal women with osteoporosis: results from the Multiple Outcomes of Raloxifene Evaluation Study.","volume":"44","author":"Silverman","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R24-11-20210227","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s001980070075","article-title":"Risk of mortality following clinical fractures.","volume":"11","author":"Cauley","year":"2000","journal-title":"Osteoporos Int"},{"key":"R25-11-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-857X(05)70197-6","article-title":"The nonskeletal consequences of osteoporotic fractures: physiologic and social outcomes.","volume":"27","author":"Gold","year":"2001","journal-title":"Rheum Dis Clin North Am"},{"key":"R26-11-20210227","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1359\/jbmr.1998.13.5.763","article-title":"A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men.","volume":"13","author":"Riggs","year":"1998","journal-title":"J Bone Miner Res"},{"key":"R27-11-20210227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11914-996-0027-0","article-title":"Selecting patients for osteoporosis therapy.","volume":"4","author":"Silverman","year":"2006","journal-title":"Curr Osteoporos Rep"},{"key":"R29-11-20210227","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/jbmr.5650101125","article-title":"Risk factors for hip fracture in European women: the MEDOS Study. Mediterranean Osteoporosis Study.","volume":"10","author":"Johnell","year":"1995","journal-title":"J Bone Miner Res"},{"key":"R30-11-20210227","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/0140-6736(93)92555-8","article-title":"Bone density at various sites for prediction of hip fractures: the Study of Osteoporotic Fractures Research Group.","volume":"341","author":"Cummings","year":"1993","journal-title":"Lancet"},{"key":"R31-11-20210227","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s001980050281","article-title":"JA, Gluer CC, for the Committee of Scientific Advisors, International Osteoporosis Foundation: an update on the diagnosis and assessment of osteoporosis with densitometry.","volume":"11","year":"2000","journal-title":"Osteoporos Int"},{"key":"R32-11-20210227","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1136\/bmj.312.7041.1254","article-title":"Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures.","volume":"312","author":"Marshall","year":"1996","journal-title":"BMJ"},{"key":"R34-11-20210227","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s001980170006","article-title":"Ten-year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds.","volume":"12","author":"Kanis","year":"2001","journal-title":"Osteoporos Int"},{"key":"R35-11-20210227","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bone.2003.12.022","article-title":"Changes in bone mineral density explain little of the reduction in vertebral or nonvertebral fracture risk with anti-resorptive therapy.","volume":"34","author":"Delmas","year":"2004","journal-title":"Bone"},{"key":"R36-11-20210227","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","article-title":"Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis: Fracture Intervention Trial Research Group.","volume":"42","author":"Hochberg","year":"1999","journal-title":"Arthritis Rheum"},{"key":"R37-11-20210227","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1385\/JCD:7:3:255","article-title":"Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.","volume":"7","author":"Watts","year":"2004","journal-title":"J Clin Densitom"},{"key":"R38-11-20210227","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1185\/030079903125003125","article-title":"Efficacy of risedronate on clinical vertebral fractures within six months.","volume":"20","author":"Roux","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"R39-11-20210227","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial.","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"R40-11-20210227","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bone.2004.06.017","article-title":"A family history of fracture and fracture risk: a meta-analysis.","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"R41-11-20210227","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomized trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"R42-11-20210227","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1001\/jama.280.24.2077","article-title":"Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial.","volume":"280","author":"Cummings","year":"1998","journal-title":"JAMA"},{"key":"R43-11-20210227","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1093\/oxfordjournals.aje.a009541","article-title":"H, de Laet CE, van Daele, et al. Risk factors for increased bone loss in an elderly population: the Rotterdam study.","volume":"147","year":"1998","journal-title":"Am J Epidemiol"},{"key":"R44-11-20210227","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/jbmr.5650060606","article-title":"Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates.","volume":"6","author":"Slemenda","year":"1991","journal-title":"J Bone Miner Res"},{"key":"R45-11-20210227","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI113125","article-title":"Genetic determinants of bone mass in adults: a twin study.","volume":"80","author":"Pocock","year":"1987","journal-title":"J Clin Invest"},{"key":"R46-11-20210227","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-118-9-199305010-00001","article-title":"Factors associated with appendicular bone mass in older women: the Study of Osteoporotic Fractures Research Group.","volume":"118","author":"Bauer","year":"1993","journal-title":"Ann Intern Med"},{"key":"R47-11-20210227","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1056\/NEJM198903023200903","article-title":"Reduced bone mass in daughters of women with osteoporosis.","volume":"320","author":"Seeman","year":"1989","journal-title":"N Engl J Med"},{"key":"R48-11-20210227","doi-asserted-by":"crossref","first-page":"870","DOI":"10.7326\/0003-4819-109-11-870","article-title":"Bone mass is low in relatives of osteoporotic patients.","volume":"109","author":"Evans","year":"1988","journal-title":"Ann Intern Med"},{"key":"R49-11-20210227","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and fracture risk.","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"R50-11-20210227","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1056\/NEJM199503233321202","article-title":"Risk factors for hip fracture in white women: Study of Osteoporotic Fractures Research Group.","volume":"332","author":"Cummings","year":"1995","journal-title":"N Engl J Med"},{"key":"R51-11-20210227","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s001980170062","article-title":"Risk factors for osteoporosis related to their outcome: fractures.","volume":"12","author":"van der Voort","year":"2001","journal-title":"Osteoporos Int"},{"key":"R52-11-20210227","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1359\/jbmr.2000.15.10.1965","article-title":"Characterization of perimenopausal bone loss: a prospective study.","volume":"15","author":"Recker","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R53-11-20210227","first-page":"277","article-title":"Vertebral bone loss in perimenopause: results of a 7-year longitudinal study.","volume":"25","author":"Pouilles","year":"1996","journal-title":"Presse Med"},{"key":"R54-11-20210227","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00198-004-1674-6","article-title":"Prediction of incident osteoporotic fractures in elderly women using the free estradiol index.","volume":"16","author":"Devine","year":"2005","journal-title":"Osteoporos Int"},{"key":"R55-11-20210227","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/jbmr.5650090304","article-title":"Influence of early age at menopause on vertebral bone mass.","volume":"9","author":"Pouilles","year":"1994","journal-title":"J Bone Miner Res"},{"key":"R56-11-20210227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/8756-3282(95)00480-7","article-title":"Decreased bone mineral density associated with early menopause progresses for at least ten years: cross-sectional comparisons between early and normal menopausal women.","volume":"18","author":"Ohta","year":"1996","journal-title":"Bone"},{"key":"R57-11-20210227","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s00774-004-0497-z","article-title":"Bone mineral density in old age: the influence of age at menarche and menopause.","volume":"22","author":"Gerdhem","year":"2004","journal-title":"J Bone Miner Metab"},{"key":"R58-11-20210227","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/archinte.164.4.420","article-title":"Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls.","volume":"164","author":"Orstavik","year":"2004","journal-title":"Arch Intern Med"},{"key":"R59-11-20210227","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1359\/jbmr.2001.16.4.782","article-title":"Inhaled corticosteroids reduce bone mineral density in early postmenopausal but not premenopausal asthmatic women.","volume":"16","author":"Fujita","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R60-11-20210227","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.2001.16.3.581","article-title":"Use of inhaled corticosteroids and risk of fractures.","volume":"16","author":"van Staa","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R61-11-20210227","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses.","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology"},{"key":"R62-11-20210227","first-page":"CD001297","article-title":"Gonadotrophin-releasing hormone analogues for endometriosis: bone mineral density.","volume":"4","author":"Sagsveen","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R63-11-20210227","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.fertnstert.2004.04.064","article-title":"Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.","volume":"82","author":"Clark","year":"2004","journal-title":"Fertil Steril"},{"key":"R64-11-20210227","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/00001648-200209000-00015","article-title":"Injectable hormone contraception and bone density: results from a prospective study.","volume":"13","author":"Scholes","year":"2002","journal-title":"Epidemiology"},{"key":"R65-11-20210227","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1359\/jbmr.060508","article-title":"R, Hannon RA, Cuzick J, Dowsett M, Clack G, Adams JE, for the ATAC Trialists' group. Effect of an aromatase inhibitor on BMD and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial.","volume":"21","year":"2006","journal-title":"J Bone Miner Res"},{"key":"R66-11-20210227","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1185\/030079907X187919","article-title":"Assessing the risk of fracture in postmenopausal women who are receiving adjuvant hormonal therapy for breast cancer.","volume":"23","author":"Bell","year":"2007","journal-title":"Curr Med Res Opin"},{"issue":"suppl 6","key":"R67-11-20210227","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1007\/s001980070002","article-title":"The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.","volume":"11","author":"Delmas","year":"2000","journal-title":"Osteoporos Int"},{"issue":"Suppl 16","key":"R68-11-20210227","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1007\/s001980070006","article-title":"Markers of bone turnover for the prediction of fracture risk.","volume":"11","author":"Garnero","year":"2000","journal-title":"Osteoporosis Int"},{"key":"R69-11-20210227","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1359\/jbmr.081004","article-title":"Association between change in bone mineral density (BMD) and fragility fracture in women and men.","volume":"24","author":"Berger","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R70-11-20210227","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy.","volume":"48","author":"van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"R71-11-20210227","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s00198-004-1709-z","article-title":"Accuracy of height loss during prospective monitoring for detection of incident vertebral fractures.","volume":"16","author":"Siminoski","year":"2005","journal-title":"Osteoporos Int"},{"issue":"suppl","key":"R72-11-20210227","doi-asserted-by":"crossref","first-page":"179S","DOI":"10.1016\/8756-3282(95)00499-8","article-title":"Vertebral fracture epidemiology.","volume":"18","author":"Wasnich","year":"1996","journal-title":"Bone"},{"key":"R73-11-20210227","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/BF01622258","article-title":"Comparison of semiquantitative and quantitative techniques for the assessment of prevalent and incident vertebral fractures.","volume":"5","author":"Wu","year":"1995","journal-title":"Osteoporos Int"},{"key":"R74-11-20210227","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/BF02556559","article-title":"Change in vertebral shape in spinal osteoporosis.","volume":"44","author":"Hedlund","year":"1989","journal-title":"Calcif Tissue Int"},{"key":"R75-11-20210227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archinte.165.8.905","article-title":"Incidental vertebral fractures discovered with chest radiography in the emergency department: prevalence, recognition, and osteoporosis management in a cohort of elderly patients.","volume":"165","author":"Majumdar","year":"2005","journal-title":"Arch Intern Med"},{"key":"R76-11-20210227","first-page":"747","article-title":"Kyphosis does not equal vertebral fractures: the Rancho Bernardo study.","volume":"31","author":"Schneider","year":"2004","journal-title":"J Rheumatol"},{"key":"R77-11-20210227","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1385\/JCD:4:4:373","article-title":"Instant vertebral assessment: a noninvasive dual x-ray absorptiometry technique to avoid misclassification and clinical mismanagement of osteoporosis.","volume":"4","author":"Greenspan","year":"2001","journal-title":"J Clin Densitom"},{"key":"R78-11-20210227","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1359\/jbmr.2000.15.3.575","article-title":"Identification of vertebral deformities in women: comparison of radiological assessment and quantitative morphometry using morphometric radiography and morphometric x-ray absorptiometry.","volume":"15","author":"Ferrar","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R79-11-20210227","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/jbmr.5650080915","article-title":"Vertebral fracture assessment using a semiquantitative technique.","volume":"8","author":"Genant","year":"1993","journal-title":"J Bone Miner Res"},{"key":"R80-11-20210227","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/jbmr.5650110716","article-title":"Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis: the Study of Osteoporotic Fractures Research Group.","volume":"11","author":"Genant","year":"1996","journal-title":"J Bone Miner Res"},{"key":"R81-11-20210227","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1532-5415.1999.tb01898.x","article-title":"Drugs and falls in older people: a systematic review and meta-analysis.","volume":"47","author":"Leipzig","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"R82-11-20210227","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1056\/NEJM198812293192604","article-title":"Risk factors for falls among elderly persons living in the community.","volume":"319","author":"Tinetti","year":"1988","journal-title":"N Engl J Med"},{"key":"R83-11-20210227","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00198-008-0794-9","article-title":"Preventative effect of exercise against falls in the elderly: a randomized controlled trial.","volume":"20","author":"Iwamoto","year":"2009","journal-title":"Osteoporos Int"},{"key":"R84-11-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1532-5415.2007.01630.x","article-title":"Extent of implementation of evidence-based fall prevention practices for older patients in home health care.","volume":"56","author":"Fortinsky","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"R85-11-20210227","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00198-004-1780-5","article-title":"Assessment of fracture risk.","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"R86-11-20210227","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","article-title":"Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.","volume":"286","author":"Siris","year":"2001","journal-title":"JAMA"},{"key":"R87-11-20210227","first-page":"293","article-title":"American Association of Clinical Endocrinologists 2001 medical guidelines for clinical practice for the prevention and management of postmenopausal osteoporosis.","volume":"7","author":"Hodgson","year":"2001","journal-title":"Endocr Pract"},{"key":"R88-11-20210227","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/aje\/kwg265","article-title":"Weight loss: a determinant of hip bone loss in older men and women. The Rancho Bernardo Study.","volume":"158","author":"Knoke","year":"2003","journal-title":"Am J Epidemiol"},{"key":"R89-11-20210227","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s00198-006-0218-7","article-title":"Potential for bone turnover markers to cost-effectively identify and select post-menopausal osteopenic women at high risk of fracture for bisphosphonate therapy.","volume":"18","author":"Schousboe","year":"2007","journal-title":"Osteoporos Int"},{"key":"R90-11-20210227","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1359\/jbmr.090310","article-title":"Effects of yearly zoledronic acid 5 mg on bone turnover markers and relation of PINP with fracture reduction in postmenopausal women with osteoporosis.","volume":"25","author":"Delmas","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R91-11-20210227","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1359\/jbmr.1999.14.9.1583","article-title":"The relationship of biochemical markers of bone turnover to bone density changes in postmenopausal women: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial.","volume":"14","author":"Marcus","year":"1999","journal-title":"J Bone Miner Res"},{"key":"R92-11-20210227","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1385\/JCD:2:3:323","article-title":"Practical clinical applications of biochemical markers of bone turnover: consensus of an expert panel.","volume":"2","author":"Miller","year":"1999","journal-title":"J Clin Densitom"},{"key":"R93-11-20210227","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1185\/030079905X41390","article-title":"How useful are measures of BMD and bone turnover?","volume":"21","author":"Miller","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"R94-11-20210227","doi-asserted-by":"crossref","first-page":"b2266","DOI":"10.1136\/bmj.b2266","article-title":"Value of routine monitoring of bone mineral density after starting bisphosphonate treatment: secondary analysis of trial data.","volume":"338","author":"Bell","year":"2009","journal-title":"BMJ"},{"key":"R95-11-20210227","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1046\/j.1532-5415.2003.51558.x","article-title":"Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women.","volume":"51","author":"Ensrud","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"R96-11-20210227","first-page":"1","article-title":"Healthy eating index scores among adults, 60 years of age and over, by sociodemographic and health characteristics: United States, 1999-2002.","volume":"395","author":"Ervin","year":"2008","journal-title":"Adv Data"},{"key":"R97-11-20210227","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archinte.166.8.869","article-title":"Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women.","volume":"166","author":"Prince","year":"2006","journal-title":"Arch Intern Med"},{"key":"R98-11-20210227","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures.","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"R99-11-20210227","first-page":"1","article-title":"Dietary intake of selected minerals for the United States population: 1999-2000.","volume":"341","author":"Ervin","year":"2004","journal-title":"Adv Data"},{"key":"R100-11-20210227","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI107461","article-title":"Effect of dietary calcium and age on jejunal calcium absorption in humans studies by intestinal perfusion.","volume":"52","author":"Ireland","year":"1973","journal-title":"J Clin Invest"},{"key":"R101-11-20210227","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2004-2364","article-title":"Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy.","volume":"90","author":"Holick","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R102-11-20210227","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1210\/jcem.86.3.7327","article-title":"A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.","volume":"86","author":"Lips","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R103-11-20210227","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s001980050110","article-title":"Urinary calcium in perimenopausal women: normative values.","volume":"9","author":"Heaney","year":"1999","journal-title":"Osteoporos Int"},{"key":"R105-11-20210227","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1001\/jama.272.24.1942","article-title":"NIH consensus development panel on optimal calcium Intake. Optimal calcium intake.","volume":"272","year":"1994","journal-title":"JAMA"},{"issue":"Suppl 10","key":"R107-11-20210227","first-page":"S1","article-title":"2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.","volume":"167","author":"Brown","year":"2002","journal-title":"CMAJ"},{"key":"R109-11-20210227","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/HYPERTENSIONAHA.107.107821","article-title":"Dietary intakes of dairy products, calcium, and vitamin D and the risk of hypertension in middle-aged and older women.","volume":"51","author":"Wang","year":"2008","journal-title":"Hypertension"},{"key":"R110-11-20210227","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/01.gme.0000243566.25205.0b","article-title":"The role of calcium in peri- and postmenopausal women: 2006 position statement of The North American Menopause Society.","volume":"13","year":"2006","journal-title":"Menopause"},{"key":"R111-11-20210227","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/07315724.2008.10719734","article-title":"Calcium supplementation and incident kidney stone risk: a systematic review.","volume":"27","author":"Heaney","year":"2008","journal-title":"J Am Coll Nutr"},{"key":"R112-11-20210227","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1359\/jbmr.081219","article-title":"Optimal vitamin D status.","volume":"24","author":"Heaney","year":"2009","journal-title":"J Bone Miner Res"},{"key":"R113-11-20210227","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s00198-005-1867-7","article-title":"Estimates of optimal vitamin D status.","volume":"16","author":"Dawson-Hughes","year":"2005","journal-title":"Osteoporos Int"},{"key":"R114-11-20210227","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes.","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"R115-11-20210227","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00060793-200202000-00011","article-title":"Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health.","volume":"9","author":"Holick","year":"2002","journal-title":"Curr Opin Endocrinol Diabetes"},{"key":"R117-11-20210227","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1210\/jc.2006-2250","article-title":"Low vitamin D status despite abundant sun exposure.","volume":"92","author":"Binkley","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"R118-11-20210227","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/ajcn\/85.1.6","article-title":"Risk assessment for vitamin D.","volume":"85","author":"Hathcock","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"R119-11-20210227","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1093\/ajcn\/68.4.854","article-title":"Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2.","volume":"68","author":"Trang","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"R120-11-20210227","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1210\/jc.2004-0360","article-title":"Vitamin D2 is much less effective than vitamin D3 in humans.","volume":"89","author":"Armas","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R121-11-20210227","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/jc.2007-2308","article-title":"Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D.","volume":"93","author":"Holick","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl","key":"R122-11-20210227","doi-asserted-by":"crossref","first-page":"1706S","DOI":"10.1093\/ajcn\/80.6.1706S","article-title":"Functional indices of vitamin D status and ramifications of vitamin D deficiency.","volume":"80","author":"Heaney","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R123-11-20210227","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","article-title":"Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial.","volume":"365","author":"Grant","year":"2005","journal-title":"Lancet"},{"key":"R124-11-20210227","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1001\/jama.293.18.2257","article-title":"Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials.","volume":"293","author":"Bischoff-Ferrari","year":"2005","journal-title":"JAMA"},{"key":"R125-11-20210227","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1056\/NEJM199009273231305","article-title":"A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women.","volume":"23","author":"Dawson-Hughes","year":"1990","journal-title":"N Engl J Med"},{"key":"R126-11-20210227","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1359\/jbmr.2003.18.2.343","article-title":"Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial.","volume":"18","author":"Bischoff","year":"2003","journal-title":"J Bone Miner Res"},{"key":"R127-11-20210227","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1359\/jbmr.2000.15.6.1113","article-title":"Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women.","volume":"15","author":"Pfeifer","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R128-11-20210227","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s00198-005-0030-9","article-title":"Is fall prevention by vitamin D mediated by a change in postural or dynamic balance?","volume":"17","author":"Bischoff-Ferrari","year":"2006","journal-title":"Osteoporos Int"},{"key":"R129-11-20210227","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1001\/jama.291.16.1999","article-title":"Effect of vitamin D on falls: a meta-analysis.","volume":"291","author":"Bischoff-Ferrari","year":"2004","journal-title":"JAMA"},{"key":"R131-11-20210227","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00223-002-2084-4","article-title":"Vitamin K1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age.","volume":"73","author":"Braam","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"R132-11-20210227","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1359\/jbmr.070116","article-title":"Two-year randomized controlled trial of vitamin K1 (phylloquinone) and Vitamin D3 plus calcium on the bone health of older women.","volume":"22","author":"Bolton-Smith","year":"2007","journal-title":"J Bone Miner Res"},{"key":"R133-11-20210227","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1371\/journal.pmed.0050196","article-title":"Vitamin K supplementation in postmenopausal women with osteopenia (ECKO Trial): a randomized controlled trial.","volume":"5","author":"Cheung","year":"2008","journal-title":"PLoS Med"},{"key":"R134-11-20210227","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1177\/147323000703500514","article-title":"Magnesium, zinc and copper status in osteoporotic, osteopenic and normal post-menopausal women.","volume":"35","author":"Mutlu","year":"2007","journal-title":"J Int Med Res"},{"key":"R135-11-20210227","doi-asserted-by":"crossref","first-page":"1232S","DOI":"10.1093\/ajcn\/81.5.1232","article-title":"Osteoporosis: the role of micronutrients.","volume":"81","author":"Nieves","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"R136-11-20210227","doi-asserted-by":"crossref","first-page":"564","DOI":"10.47102\/annals-acadmedsg.V37N7p564","article-title":"Magnesium, zinc, copper, manganese, and selenium levels in postmenopausal women with osteoporosis. Can magnesium play a key role in osteoporosis?","volume":"37","author":"Odabasi","year":"2008","journal-title":"Ann Acad Med Singapore"},{"key":"R137-11-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1080\/07315724.1994.10718439","article-title":"Effect of magnesium on the intestinal absorption of calcium in man.","volume":"13","author":"Spencer","year":"1994","journal-title":"J Am Coll Nutr"},{"key":"R138-11-20210227","first-page":"25","article-title":"Magnesium status and ageing: an update.","volume":"11","author":"Durlach","year":"1998","journal-title":"Magnes Res"},{"key":"R139-11-20210227","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/BF01629578","article-title":"Magnesium deficiency: possible role in osteoporosis associated with gluten-sensitive enteropathy.","volume":"6","author":"Rude","year":"1996","journal-title":"Osteoporos Int"},{"key":"R140-11-20210227","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1359\/jbmr.2000.15.12.2504","article-title":"Effect of dietary protein on bone loss in elderly men and women: the Framingham Osteoporosis Study.","volume":"15","author":"Hannan","year":"2000","journal-title":"J Bone Miner Res"},{"key":"R141-11-20210227","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ajcn\/77.6.1517","article-title":"Protein intake: effects on bone mineral density and the rate of bone loss in elderly women.","volume":"77","author":"Rapuri","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"R142-11-20210227","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1080\/07315724.1992.10718256","article-title":"Benefits of oral protein supplementation in elderly patients with fracture of the proximal femur.","volume":"11","author":"Tkatch","year":"1992","journal-title":"J Am Coll Nutr"},{"key":"R143-11-20210227","doi-asserted-by":"crossref","first-page":"1567S","DOI":"10.1093\/ajcn\/87.5.1567S","article-title":"Amount and type of protein influences bone health.","volume":"87","author":"Heaney","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R144-11-20210227","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1079\/PNS2003309","article-title":"Dietary phyto-oestrogens and bone health.","volume":"62","author":"Branca","year":"2003","journal-title":"Proc Nutr Soc"},{"key":"R145-11-20210227","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1001\/jama.285.11.1482","article-title":"Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial. Ipriflavone Multicenter European Fracture Study.","volume":"285","author":"Alexandersen","year":"2001","journal-title":"JAMA"},{"key":"R146-11-20210227","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/01.GME.0000094394.59028.46","article-title":"Beneficial effect of soy isoflavones on bone mineral content was modified by years since menopause, body weight, and calcium intake: a double-blind, randomized, controlled trial.","volume":"11","author":"Chen","year":"2004","journal-title":"Menopause"},{"key":"R147-11-20210227","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1079\/PNS2005476","article-title":"Critical review of health effects of soyabean phyto-oestrogens in post-menopausal women.","volume":"65","author":"Cassidy","year":"2006","journal-title":"Proc Nutr Soc"},{"key":"R148-11-20210227","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.clnu.2007.10.012","article-title":"Soy isoflavone intake increases bone mineral density in the spine of menopausal women: meta-analysis of randomized controlled trials.","volume":"27","author":"Ma","year":"2008","journal-title":"Clin Nutr"},{"key":"R149-11-20210227","doi-asserted-by":"crossref","first-page":"839","DOI":"10.7326\/0003-4819-146-12-200706190-00005","article-title":"Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial.","volume":"146","author":"Marini","year":"2007","journal-title":"Ann Intern Med"},{"key":"R150-11-20210227","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.292.1.65","article-title":"Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.","volume":"292","author":"Kreijkamp-Kaspers","year":"2004","journal-title":"JAMA"},{"key":"R151-11-20210227","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/01.GME.0000097845.95550.71","article-title":"The effect of soy protein isolate on bone metabolism.","volume":"11","author":"Gallagher","year":"2004","journal-title":"Menopause"},{"key":"R152-11-20210227","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ajcn\/79.2.326","article-title":"The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial.","volume":"79","author":"Atkinson","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"R153-11-20210227","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ajcn\/87.3.761","article-title":"Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study.","volume":"87","author":"Brink","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"R154-11-20210227","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.bone.2008.12.020","article-title":"Effect of long-term intervention of soy isoflavones on bone mineral density in women: a meta-analysis of randomized controlled trials.","volume":"44","author":"Liu","year":"2009","journal-title":"Bone"},{"key":"R155-11-20210227","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1007\/s001980170069","article-title":"The effects of lifestyle, dietary dairy intake and diabetes on bone density and vertebral deformity prevalence: the EVOS study.","volume":"12","author":"Lunt","year":"2001","journal-title":"Osteoporos Int"},{"key":"R156-11-20210227","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/aje\/kwn407","article-title":"Lifestyle impact on lifetime bone loss in women and men: the Tromso Study.","volume":"169","author":"Wilsgaard","year":"2009","journal-title":"Am J Epidemiol"},{"key":"R157-11-20210227","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00005768-199703000-00002","article-title":"Exercise and bone mineral density in mature female athletes.","volume":"29","author":"Dook","year":"1997","journal-title":"Med Sci Sports Exerc"},{"key":"R158-11-20210227","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/8756-3282(94)90289-5","article-title":"The site-specific effects of long-term unilateral activity on bone mineral density and content.","volume":"15","author":"Kannus","year":"1994","journal-title":"Bone"},{"key":"R159-11-20210227","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1359\/JBMR.0301245","article-title":"Effect of 6-month whole body vibration training on hip density, muscle strength, and postural control in postmenopausal women: a randomized controlled pilot study.","volume":"19","author":"Verschueren","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R160-11-20210227","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1359\/JBMR.0301251","article-title":"Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety.","volume":"19","author":"Rubin","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R161-11-20210227","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/jbmr.5650070706","article-title":"Effects of resistance and endurance exercise on bone mineral status of young women: a randomized exercise intervention trial.","volume":"7","author":"Snow-Harter","year":"1992","journal-title":"J Bone Miner Res"},{"key":"R162-11-20210227","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/gerona\/57.9.M599","article-title":"Exercise and lumbar spine bone mineral density in postmenopausal women: a meta-analysis of individual patient data.","volume":"57","author":"Kelley","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"R163-11-20210227","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1002\/jbmr.5650060609","article-title":"Estrogen therapy and variable-resistance weight training increase bone mineral in surgically menopausal women.","volume":"6","author":"Notelovitz","year":"1991","journal-title":"J Bone Miner Res"},{"key":"R164-11-20210227","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1046\/j.1532-5415.2002.50218.x","article-title":"Preventing injuries in older people by preventing falls: a meta-analysis of individual-level data.","volume":"50","author":"Robertson","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"R165-11-20210227","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S8756-3282(02)00739-1","article-title":"Stronger back muscles reduce the incidence of vertebral fractures: a prospective 10 year follow-up of postmenopausal women.","volume":"30","author":"Sinkai","year":"2002","journal-title":"Bone"},{"key":"R166-11-20210227","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4065\/83.1.54","article-title":"Significantly fewer refractures after vertebroplasty in patients who engage in back-extensor-strengthening exercises.","volume":"83","author":"Huntoon","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"R167-11-20210227","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00198-007-0398-9","article-title":"Effect of low-intensity back exercise on quality of life and back extensor strength in patients with osteoporosis: a randomized controlled trial.","volume":"18","author":"Hongo","year":"2007","journal-title":"Osteoporos Int"},{"key":"R168-11-20210227","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/S0140-6736(02)08657-9","article-title":"Epidemiology and outcomes of osteoporotic fractures.","volume":"359","author":"Cummings","year":"2002","journal-title":"Lancet"},{"key":"R169-11-20210227","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/oxfordjournals.aje.a116681","article-title":"Incidence of and risk factors for falls and injurious falls among the community-dwelling elderly.","volume":"137","author":"O'Loughlin","year":"1993","journal-title":"Am J Epidemiol"},{"key":"R170-11-20210227","first-page":"CD000340","article-title":"Interventions for preventing falls in elderly people.","volume":"4","author":"Gillespie","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"R171-11-20210227","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/j.1532-5415.1999.tb03843.x","article-title":"Psychotropic medication withdrawal and a home-based exercise program to prevent falls: a randomized, controlled trial.","volume":"47","author":"Campbell","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"R172-11-20210227","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/ip.9.2.138","article-title":"A randomised trial of hip protector use by frail older women living in their own homes.","volume":"9","author":"Cameron","year":"2003","journal-title":"Inj Prev"},{"key":"R173-11-20210227","first-page":"CD001255","article-title":"Hip protectors for preventing hip fractures in older people.","volume":"3","author":"Parker","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R174-11-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/jbmr.5650040513","article-title":"Cigarette smoking, obesity, and bone mass.","volume":"4","author":"Slemenda","year":"1989","journal-title":"J Bone Miner Res"},{"key":"R175-11-20210227","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/S0895-4356(98)00119-X","article-title":"Prospective study of factors influencing the onset of natural menopause.","volume":"51","author":"Kato","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"R176-11-20210227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jbmr.5650060404","article-title":"Smoking and bone loss among postmenopausal women.","volume":"6","author":"Krall","year":"1991","journal-title":"J Bone Miner Res"},{"key":"R177-11-20210227","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/archinte.161.7.983","article-title":"Cigarette smoking, alcohol consumption, and risk for hip fracture in women.","volume":"161","author":"Baron","year":"2001","journal-title":"Arch Intern Med"},{"key":"R178-11-20210227","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00198-004-1640-3","article-title":"Smoking and fracture risk: a meta-analysis.","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"R179-11-20210227","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S8756-3282(00)00341-0","article-title":"Smoking and bone metabolism in elderly women.","volume":"27","author":"Rapuri","year":"2000","journal-title":"Bone"},{"key":"R180-11-20210227","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1359\/jbmr.1999.14.2.215","article-title":"Smoking increases bone loss and decreases intestinal calcium absorption.","volume":"14","author":"Krall","year":"1999","journal-title":"J Bone Miner Res"},{"key":"R181-11-20210227","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJM198510173131602","article-title":"Cigarette smoking, serum estrogens and bone loss during hormone replacement therapy early after menopause.","volume":"313","author":"Jensen","year":"1985","journal-title":"N Engl J Med"},{"key":"R182-11-20210227","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1136\/bmj.315.7112.841","article-title":"A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect.","volume":"315","author":"Law","year":"1997","journal-title":"BMJ"},{"key":"R183-11-20210227","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.3945\/ajcn.2008.26765","article-title":"Effects of beer, wine, and liquor intakes on bone mineral density in older men and women.","volume":"89","author":"Tucker","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"R184-11-20210227","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1093\/oxfordjournals.aje.a117664","article-title":"Alcohol intake and bone mineral density in elderly men and women: the Framingham Study.","volume":"142","author":"Felson","year":"1995","journal-title":"Am J Epidemiol"},{"key":"R185-11-20210227","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/oxfordjournals.aje.a115052","article-title":"Alcohol consumption and hip fractures: the Framingham Study.","volume":"128","author":"Felson","year":"1988","journal-title":"Am J Epidemiol"},{"key":"R186-11-20210227","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.alcohol.2008.04.004","article-title":"The contribution of alcohol to falls at home among working-aged adults.","volume":"42","author":"Kool","year":"2008","journal-title":"Alcohol"},{"key":"R187-11-20210227","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-004-1734-y","article-title":"Alcohol intake as a risk factor for fracture.","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos Int"},{"key":"R188-11-20210227","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis.","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas"},{"key":"R189-11-20210227","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","article-title":"Early discontinuation of treatment for osteoporosis.","volume":"115","author":"Tosteson","year":"2003","journal-title":"Am J Med"},{"key":"R190-11-20210227","first-page":"859","article-title":"Compliance of osteoporotic patients with different treatment regimens.","volume":"5","author":"Segal","year":"2003","journal-title":"Isr Med Assoc J"},{"key":"R191-11-20210227","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0889-8529(02)00079-8","article-title":"Bisphosphonates.","volume":"32","author":"McClung","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R192-11-20210227","first-page":"1","article-title":"Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis. Alendronate Once-Weekly Study Group.","volume":"12","author":"Schnitzer","year":"2000","journal-title":"Aging (Milano)"},{"key":"R193-11-20210227","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00223-002-2011-8","article-title":"The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis.","volume":"71","author":"Brown","year":"2002","journal-title":"Calcif Tissue Int"},{"key":"R194-11-20210227","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1359\/JBMR.050313","article-title":"Monthly oral ibandronate therapy in postmenopausal osteoporosis: 1-year results from the MOBILE study.","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R196-11-20210227","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-128-4-199802150-00001","article-title":"Alendronate prevents postmenopausal bone loss in women without osteoporosis: a double-blind, randomized, controlled trial.","volume":"128","author":"McClung","year":"1998","journal-title":"Ann Intern Med"},{"key":"R197-11-20210227","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.1210\/jc.2003-031672","article-title":"Prevention of postmenopausal bone loss: six-year results from the Early Postmenopausal Intervention Cohort Study.","volume":"89","author":"McClung","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"R198-11-20210227","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","article-title":"Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis.","volume":"333","author":"Liberman","year":"1995","journal-title":"N Engl J Med"},{"key":"R199-11-20210227","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1359\/JBMR.040326","article-title":"Randomized trial of effect of alendronate continuation versus discontinuation in women with low BMD: results from the Fracture Intervention Trial long-term extension.","volume":"19","author":"Ensrud","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R200-11-20210227","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1056\/NEJMoa030897","article-title":"Ten years' experience with alendronate for osteoporosis in postmenopausal women.","volume":"350","author":"Bone","year":"2004","journal-title":"N Engl J Med"},{"key":"R201-11-20210227","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures: Fracture Intervention Trial Research Group.","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"R202-11-20210227","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. Fracture Intervention Trial Research Group.","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R203-11-20210227","first-page":"396","article-title":"Risedronate increases bone mass in an early postmenopausal population: two years of treatment plus one year of follow-up.","volume":"83","author":"Mortensen","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"R204-11-20210227","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1007\/s00223-004-0286-7","article-title":"Seven years of treatment with risedronate in women with postmenopausal osteoporosis.","volume":"75","author":"Mellstrom","year":"2004","journal-title":"Calcif Tissue Int"},{"key":"R205-11-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"key":"R206-11-20210227","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1056\/NEJM200102013440503","article-title":"Effect of risedronate on the risk of hip fracture in elderly women. Hip Intervention Program Study Group.","volume":"344","author":"McClung","year":"2001","journal-title":"N Engl J Med"},{"key":"R207-11-20210227","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S8756-3282(02)00946-8","article-title":"Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience.","volume":"32","author":"Sorensen","year":"2003","journal-title":"Bone"},{"key":"R208-11-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.0301202","article-title":"Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis.","volume":"19","author":"McClung","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R209-11-20210227","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1359\/JBMR.040325","article-title":"Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.","volume":"19","author":"Chesnut","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R210-11-20210227","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa067312","article-title":"Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.","volume":"356","author":"Black","year":"2007","journal-title":"N Engl J Med"},{"key":"R211-11-20210227","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s001980170147","article-title":"A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporosis Research Advisory Group.","volume":"12","author":"Cranney","year":"2001","journal-title":"Osteoporos Int"},{"issue":"suppl","key":"R212-11-20210227","first-page":"S945","article-title":"Use of bisphosphonates in the treatment of osteoporosis: prevention and management of osteoporosis: consensus statements from the scientific advisory board of the Osteoporosis Society of Canada.","volume":"155","author":"Hodsman","year":"1996","journal-title":"Can Med Assoc J"},{"key":"R213-11-20210227","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","article-title":"Severely suppressed bone turnover: a potential complication of alendronate therapy.","volume":"90","author":"Odvina","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R214-11-20210227","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00198-008-0805-x","article-title":"Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.","volume":"20","author":"Lenart","year":"2008","journal-title":"Osteoporos Int"},{"key":"R215-11-20210227","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1097\/BOT.0b013e318172841c","article-title":"Low-energy femoral shaft fractures associated with alendronate use.","volume":"22","author":"Neviaser","year":"2008","journal-title":"J Orthop Trauma"},{"key":"R216-11-20210227","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.joms.2004.02.004","article-title":"Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases.","volume":"62","author":"Ruggiero","year":"2004","journal-title":"J Oral Maxillofac Surg"},{"key":"R217-11-20210227","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.14219\/jada.archive.2005.0108","article-title":"Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper.","volume":"136","author":"Migliorati","year":"2005","journal-title":"J Am Dent Assoc"},{"key":"R218-11-20210227","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/j.joms.2005.07.010","article-title":"Bisphosphonate-induced exposed bone (osteonecrosis\/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment.","volume":"63","author":"Marx","year":"2005","journal-title":"J Oral Maxillofac Surg"},{"key":"R219-11-20210227","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/cncr.21130","article-title":"Bisphosphonate-associated osteonecrosis of mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy.","volume":"104","author":"Migliorati","year":"2005","journal-title":"Cancer"},{"key":"R220-11-20210227","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.GME.0000123641.76105.B5","article-title":"Changes in bone density and turnover after alendronate or estrogen withdrawal.","volume":"11","author":"Wasnich","year":"2004","journal-title":"Menopause"},{"key":"R221-11-20210227","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1007\/s00198-008-0604-4","article-title":"Risk of hip fracture after bisphosphonate discontinuation: implications for a drug holiday.","volume":"19","author":"Curtis","year":"2008","journal-title":"Osteoporos Int"},{"key":"R222-11-20210227","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00198-007-0460-7","article-title":"Fracture risk remains reduced one year after discontinuation of risedronate.","volume":"19","author":"Watts","year":"2008","journal-title":"Osteoporos Int"},{"key":"R223-11-20210227","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199712043372301","article-title":"Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women.","volume":"337","author":"Delmas","year":"1997","journal-title":"N Engl J Med"},{"key":"R224-11-20210227","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"R225-11-20210227","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1210\/jcem.87.8.8750","article-title":"Efficacy of raloxifene on vertebral fracture risk reduction in postmenopausal women with osteoporosis: four-year results from a randomized clinical trial.","volume":"87","author":"Delmas","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R226-11-20210227","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/archinte.162.10.1140","article-title":"Early effects of raloxifene on clinical vertebral fractures at 12 months in postmenopausal women with osteoporosis.","volume":"162","author":"Maricic","year":"2002","journal-title":"Arch Intern Med"},{"key":"R227-11-20210227","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1001\/jama.281.23.2189","article-title":"The effect of raloxifene on risk of breast cancer in postmenopausal women: results from the MORE randomized trial. Multiple Outcomes of Raloxifene Evaluation.","volume":"281","author":"Cummings","year":"1999","journal-title":"JAMA"},{"key":"R228-11-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1006478317173","article-title":"Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.","volume":"65","author":"Cauley","year":"2001","journal-title":"Breast Cancer Res Treat"},{"key":"R229-11-20210227","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1093\/jnci\/djh319","article-title":"S, Cauley JA, Barrett-Connor E, et al, for CORE Investigators. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.","volume":"96","year":"2004","journal-title":"J Natl Cancer Inst"},{"key":"R230-11-20210227","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/01.AOG.0000137349.79204.b8","article-title":"Safety and adverse effects associated with raloxifene: multiple outcomes of raloxifene evaluation.","volume":"104","author":"Grady","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R231-11-20210227","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jama.287.7.847","article-title":"E, Grady D, Sashegvi A, et al, for the MORE Investigators (Multiple Outcomes of Raloxifene Evaluation). Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial.","volume":"287","year":"2002","journal-title":"JAMA"},{"key":"R232-11-20210227","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.amjcard.2005.09.083","article-title":"Effect of raloxifene on cardiovascular adverse events in postmenopausal women with osteoporosis.","volume":"97","author":"Ensrud","year":"2006","journal-title":"Am J Cardiol"},{"key":"R233-11-20210227","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa062462","article-title":"Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women.","volume":"355","author":"Barrett- Connor","year":"2006","journal-title":"N Engl J Med"},{"key":"R234-11-20210227","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.amjmed.2009.01.033","article-title":"Raloxifene risk for stroke based on the Framingham stroke risk score.","volume":"122","author":"Barrett-Connor","year":"2009","journal-title":"Am J Med"},{"key":"R235-11-20210227","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S8756-3282(01)00706-2","article-title":"Effect of 1 year of discontinuation of raloxifene or estrogen therapy on bone mineral density after 5 years of treatment in healthy postmenopausal women.","volume":"30","author":"Neele","year":"2002","journal-title":"Bone"},{"key":"R236-11-20210227","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1359\/JBMR.050509","article-title":"ES, Harris ST, Eastell R, et al, for the Continuing Outcomes Relevant to Evista (CORE) Investigators. Skeletal effects of raloxifene after 8 years: results from the continuing outcomes relevant to Evista (CORE) study.","volume":"20","year":"2005","journal-title":"J Bone Miner Res"},{"key":"R237-11-20210227","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1359\/jbmr.2001.16.10.1846","article-title":"Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.","volume":"16","author":"Dempster","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R238-11-20210227","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)02342-8","article-title":"Randomised controlled study of effect of parathyroid hormone on vertebral-bone mass and fracture incidence among postmenopausal women on oestrogen with osteoporosis.","volume":"350","author":"Lindsay","year":"1997","journal-title":"Lancet"},{"key":"R239-11-20210227","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis.","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"R241-11-20210227","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJMoa050336","article-title":"One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis.","volume":"353","author":"Black","year":"2005","journal-title":"N Engl J Med"},{"key":"R242-11-20210227","first-page":"2129","article-title":"Enhancement of bone mass in osteoporotic women with parathyroid hormone followed by alendronate.","volume":"85","author":"Rittmaster","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R243-11-20210227","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1359\/jbmr.040117","article-title":"Differential effects of teriparatide on BMD after treatment with raloxifene or alendronate.","volume":"19","author":"Ettinger","year":"2004","journal-title":"J Bone Miner Res"},{"key":"R244-11-20210227","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1210\/er.2001-5002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women.","volume":"23","author":"Wells","year":"2002","journal-title":"Endocr Rev"},{"key":"R245-11-20210227","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1001\/jama.1996.03540170033029","article-title":"Effects of hormone therapy on bone mineral density: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) trial. The Writing Group for the PEPI.","volume":"276","year":"1996","journal-title":"JAMA"},{"key":"R246-11-20210227","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial.","volume":"290","author":"Cauley","year":"2003","journal-title":"JAMA"},{"key":"R247-11-20210227","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.287.20.2668","article-title":"Effect of lower doses of conjugated equine estrogens with and without medroxyprogesterone acetate on bone in early postmenopausal women.","volume":"287","author":"Lindsay","year":"2002","journal-title":"JAMA"},{"key":"R248-11-20210227","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.290.8.1042","article-title":"Ultralow-dose micronized 17-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.","volume":"290","author":"Prestwood","year":"2003","journal-title":"JAMA"},{"key":"R249-11-20210227","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial.","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R250-11-20210227","doi-asserted-by":"crossref","first-page":"897","DOI":"10.7326\/0003-4819-130-11-199906010-00005","article-title":"The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women: a randomized, controlled trial.","volume":"130","author":"Recker","year":"1999","journal-title":"Ann Intern Med"},{"key":"R251-11-20210227","first-page":"330","article-title":"A randomized controlled trial of four doses of transdermal estradiol for preventing postmenopausal bone loss: Transdermal Estradiol Investigator Group.","volume":"94","author":"Weiss","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R252-11-20210227","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1097\/01.GME.0000163870.03388.4D","article-title":"Bone mineral density in postmenopausal women treated with a vaginal ring delivering systemic doses of estradiol acetate.","volume":"12","author":"Al-Azzawi","year":"2005","journal-title":"Menopause"},{"key":"R253-11-20210227","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.7326\/0003-4819-117-12-1016","article-title":"Hormone therapy to prevent disease and prolong life in postmenopausal women.","volume":"117","author":"Grady","year":"1992","journal-title":"Ann Intern Med"},{"key":"R254-11-20210227","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1001\/jama.285.22.2891","article-title":"Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials.","volume":"285","author":"Torgerson","year":"2001","journal-title":"JAMA"},{"key":"R255-11-20210227","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1001\/jama.291.18.2212","article-title":"Fracture incidence in relation to the pattern of use of hormone therapy in postmenopausal women.","volume":"291","author":"Banks","year":"2004","journal-title":"JAMA"},{"key":"R256-11-20210227","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","article-title":"Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial.","volume":"291","author":"Anderson","year":"2004","journal-title":"JAMA"},{"key":"R257-11-20210227","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1001\/jama.289.24.3243","article-title":"RT, Hendrix SL, Langer RD, et al, for the WHI Investigators. Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"R258-11-20210227","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1001\/jama.289.20.2673","article-title":"S, Hendrix SL, Limacher M, et al, for the WHI Investigators. Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial.","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"R259-11-20210227","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa030808","article-title":"Estrogen plus progestin and the risk of coronary heart disease.","volume":"349","author":"Manson","year":"2003","journal-title":"N Engl J Med"},{"key":"R260-11-20210227","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.292.13.1573","article-title":"Estrogen plus progestin and risk of venous thrombosis.","volume":"292","author":"Cushman","year":"2004","journal-title":"JAMA"},{"key":"R261-11-20210227","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1001\/jama.289.20.2651","article-title":"SA, Legault C, Rapp SR, et al, for the WHIMS Investigators. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.","volume":"289","year":"2003","journal-title":"JAMA"},{"key":"R262-11-20210227","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/gme.0b013e31817b076a","article-title":"Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.","volume":"15","year":"2008","journal-title":"Menopause"},{"key":"R263-11-20210227","doi-asserted-by":"crossref","first-page":"4914","DOI":"10.1210\/jc.2002-020727","article-title":"Effect of discontinuation of estrogen, calcitriol, and the combination of both on bone density and bone markers.","volume":"87","author":"Gallagher","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"R264-11-20210227","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1001\/archinte.162.6.665","article-title":"Bone mass response to discontinuation of long-term hormone replacement therapy: results from the Postmenopausal Estrogen\/Progestin Interventions (PEPI) Safety Follow-up Study.","volume":"162","author":"Greendale","year":"2002","journal-title":"Arch Intern Med"},{"key":"R265-11-20210227","doi-asserted-by":"crossref","first-page":"875","DOI":"10.7326\/0003-4819-137-11-200212030-00008","article-title":"Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis: a randomized, double-blind, placebo-controlled trial.","volume":"137","author":"Greenspan","year":"2002","journal-title":"Ann Intern Med"},{"key":"R266-11-20210227","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s001980170107","article-title":"Withdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women.","volume":"12","author":"Tremollieres","year":"2001","journal-title":"Osteoporos Int"},{"key":"R267-11-20210227","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/01.GME.0000086467.82759.DA","article-title":"Recency and duration of postmenopausal hormone therapy: effects of bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.","volume":"10","author":"Barrett-Connor","year":"2003","journal-title":"Menopause"},{"key":"R268-11-20210227","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/01.AOG.0000114986.14806.37","article-title":"Rapid loss of hip fracture protection after estrogen cessation: evidence from the National Osteoporosis Risk Assessment.","volume":"103","author":"Yates","year":"2004","journal-title":"Obstet Gynecol"},{"key":"R269-11-20210227","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0889-8529(02)00060-9","article-title":"Calcitonin.","volume":"32","author":"Silverman","year":"2003","journal-title":"Endocrinol Metab Clin North Am"},{"key":"R270-11-20210227","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1136\/bmj.305.6853.556","article-title":"Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.","volume":"305","author":"Overgaard","year":"1992","journal-title":"BMJ"},{"key":"R271-11-20210227","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence of Osteoporotic Fractures Study. PROOF study group.","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"R272-11-20210227","first-page":"205","article-title":"Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.","volume":"11","author":"Pun","year":"1989","journal-title":"Clin Ther"},{"key":"R273-11-20210227","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00002508-199912000-00004","article-title":"Analgesic effect of salmon calcitonin suppositories in patients with acute pain due to recent osteoporotic vertebral crush fractures: a prospective double-blind, randomized, placebo-controlled clinical study.","volume":"15","author":"Lyritis","year":"1999","journal-title":"Clin J Pain"},{"key":"R274-11-20210227","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1345\/aph.1C350","article-title":"Analgesic efficacy of calcitonin for vertebral pain.","volume":"37","author":"Blau","year":"2003","journal-title":"Ann Pharmacother"},{"key":"R275-11-20210227","first-page":"720","article-title":"Alendronate and estrogen effect in postmenopausal women with low bone mineral density. Alendronate\/Estrogen Study Group.","volume":"85","author":"Bone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"R276-11-20210227","first-page":"1890","article-title":"Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.","volume":"86","author":"Harris","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R277-11-20210227","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women.","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"R278-11-20210227","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"R279-11-20210227","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1210\/jc.2004-1774","article-title":"Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: treatment of peripheral osteoporosis (TROPOS) study.","volume":"90","author":"Reginster","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"R280-11-20210227","doi-asserted-by":"crossref","first-page":"326","DOI":"10.7326\/0003-4819-146-5-200703060-00005","article-title":"Effect of recombinant human parathyroid hormone (1-84) on vertebral fracture and bone mineral density in postmenopausal women with osteoporosis: a randomized trial.","volume":"146","author":"Greenspan","year":"2007","journal-title":"Ann Intern Med"},{"key":"R281-11-20210227","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1359\/jbmr.071206","article-title":"Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study.","volume":"23","author":"Miller","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R282-11-20210227","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1359\/jbmr.080710","article-title":"Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial.","volume":"23","author":"Silverman","year":"2008","journal-title":"J Bone Miner Res"},{"issue":"Suppl 1","key":"R283-11-20210227","first-page":"S81","article-title":"The effects of lasofoxifene on fractures and breast cancer: 3-year results from the PEARL trial.","volume":"23","author":"Cummings","year":"2008","journal-title":"J Bone Miner Res"},{"key":"R284-11-20210227","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/01.gme.0000188736.69617.4f","article-title":"Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene.","volume":"13","author":"McClung","year":"2006","journal-title":"Menopause"},{"key":"R285-11-20210227","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1056\/NEJMoa044459","article-title":"Denosumab in postmenopausal women with low bone mineral density.","volume":"354","author":"McClung","year":"2006","journal-title":"N Engl J Med"},{"key":"R286-11-20210227","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"SR, Martin JS, McClung MR, et al, for the FREEDOM Trial. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.","volume":"361","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Menopause"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042192-201017010-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:08:33Z","timestamp":1786039713000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042192-201017010-00011"}},"subtitle":["2010 position statement of The North American Menopause Society"],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":276,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/gme.0b013e3181c617e6","relation":{},"ISSN":["1072-3714"],"issn-type":[{"value":"1072-3714","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}